Rheumatoid Arthritis Clinical Trials in New York

Showing 621-640 of 3,596 trials

Tensi+ for Treating Overactive Bladder: A Randomized Controlled Trial

NCT07300904

The purpose of the study is to evaluate the safety and effectiveness of the Tensi+ device using Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) for treating patients suffering from OAB symptoms urinary frequency, urgency, with or without urge urinary incontinence.

Overactive Bladder (OAB)

Stimuli Technology60 participantsStarted Mar 2026

Beverly Hills, California, United States • New York, New York, United States • Toronto, Canada

Active Not RecruitingPhase 2< 1 mile

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

NCT02864992

This study looked at how effective the study drug (tepotinib) was at stopping the growth and spread of lung cancer. This study also measures a number of other things including safety of the study drug and the side effects, how body processes the study drug, or how the study drug affects your quality of life. The study also has an optional pharmacogenetic research part. Pharmacogenetic research is an important way to try to understand the role of genetics in human disease and how genes impact the effectiveness of drugs, because differences in genes can change the way a person responds to a particular drug.

Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET AmplificationLung Adenocarcinoma Stage IIIB/IV

EMD Serono Research & Development Institute, Inc.337 participantsStarted Sep 2016

Duarte, California, United States • Encinitas, California, United States • Orange, California, United States +173 more locations

Tensi+ for Treating Overactive Bladder: A Randomized Controlled Trial

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Rheumatoid Arthritis Trials in Other Cities

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.

SP Thoracic IDE Study

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

Novel Delivery Method of Transgender Voice Therapy Using a Mobile Application

Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Ribociclib and Letrozole Treatment in Ovarian Cancer

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age

Evaluating The Safety and Effectiveness of The NeoDisc™ Versus ACDF in Subjects With Single-Level Cervical Disc Disease

Spreading Depolarizations in Traumatic Brain Injury

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

Lumbar Interbody Implant Study

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

Other Conditions in New York